Skip to main content

ARDT Investors Have Opportunity to Join Ardent Health, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ardent Health, Inc. (“Ardent” or “the Company”) (NYSE: ARDT) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Ardent announced its financial results for Q3 2025 on November 12, 2025. The Company revealed a $43 million reduction in its revenue due to accounting changes, and a $54 million increase in professional liability reserves. Based on this news, shares of Ardent plummeted by nearly 34% on the next day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm 
Brian Schall, Esq. 
310-301-3335
info@schallfirm.com

www.schallfirm.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.02
-0.53 (-0.24%)
AAPL  269.86
+2.42 (0.90%)
AMD  225.03
-5.26 (-2.28%)
BAC  52.17
+0.53 (1.04%)
GOOG  294.10
+9.14 (3.21%)
META  586.05
-11.64 (-1.95%)
MSFT  487.39
-6.40 (-1.30%)
NVDA  184.34
+2.98 (1.64%)
ORCL  223.39
+2.90 (1.32%)
TSLA  402.75
+1.50 (0.37%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.